News
BSEM
3.530
-8.31%
-0.320
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 6d ago
Weekly Report: what happened at BSEM last week (0817-0821)?
Weekly Report · 6d ago
BioStem Technologies Earnings Call: Growth Amid Strain
TipRanks · 08/22 00:16
BioStem Q2 Revenue Rises 29%; Raises 2026 Guidance, Uplists To Nasdaq
NASDAQ · 08/20 16:25
Weekly Report: what happened at BSEM last week (0810-0814)?
Weekly Report · 08/17 10:25
BioStem Technologies to Present at the Sidoti MicroCap Conference
Barchart · 08/14 15:05
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 08/13 17:05
BioStem Technologies Q2 EPS $(0.52), Sales $7.899M Down From $10.963M YoY
Benzinga · 08/12 20:30
BioStem Technologies GAAP EPS of -$0.52 misses by $0.02, revenue of $7.9M beats by $1.55M
Seeking Alpha · 08/12 20:19
Press Release: BioStem Technologies Reports -2-
Dow Jones · 08/12 20:05
Press Release: BioStem Technologies Reports Second Quarter 2026 Financial Results
Dow Jones · 08/12 20:05
BioStem’s BR-AM Trial Completion Sets the Stage for Next Moves in Diabetic Wound Care
TipRanks · 08/12 16:30
Weekly Report: what happened at BSEM last week (0803-0807)?
Weekly Report · 08/10 10:20
BioStem Technologies Uplists to Nasdaq Capital Market
TipRanks · 08/07 20:55
BioStem Technologies wins Nasdaq approval; shares to begin trading Aug. 7
Seeking Alpha · 08/06 21:43
*BioStem Technologies: Common Stk Is Expected to Begin Trading on Nasdaq on Aug 7 Under Symbol 'BSEM' >BSEM
Dow Jones · 08/06 21:42
BioStem Technologies Announces It Received Nasdaq Approval For The Company’s Common Stock For Listing On The Nasdaq Capital Market; Co. To Begin Trading On Nasdaq On August 7, 2026 Under The Ticker Symbol "BSEM"
Benzinga · 08/06 21:41
Weekly Report: what happened at BSEM last week (0727-0731)?
Weekly Report · 08/03 10:19
Weekly Report: what happened at BSEM last week (0720-0724)?
Weekly Report · 07/27 10:24
Weekly Report: what happened at BSEM last week (0713-0717)?
Weekly Report · 07/20 10:20
More
Webull provides a variety of real-time BSEM stock news. You can receive the latest news about Biostem Tech through multiple platforms. This information may help you make smarter investment decisions.
About BSEM
BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The Company's products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AMERICAN AMNION. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. It also owns BioTissue's surgical and wound care business, including the Neox and Clarix product lines.